≡

Eukaryotic Matrix Metalloproteinase 14 (MMP14)

MMP-X1; MT1-MMP; MTMMP1; Membrane Inserted; Membrane-type matrix metalloproteinase 1; Membrane-type-1 matrix metalloproteinase

  • Product No.EPC056Hu62
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceEukaryotic expression
  • Host293F Cell
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationCytoplasm
  • Predicted Molecular Mass65.4kDa
  • Accurate Molecular Mass65kDa(Analysis of differences refer to the manual)
  • Residues & TagsAla21-Ser538 With C-terminal His-tag with
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point7.4
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 242  US$ 605  US$ 1210  US$ 3630  US$ 9075 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-0.2 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cancer Research Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer Aacrjournals: Source
Anticancer Research Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro Pubmed:25202075
Endocrine GLP-1 reduces metalloproteinase-14 and soluble endoglin induced by both hyperglycemia and hypoglycemia in type 1 diabetes PubMed: 25743265
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC056Hu03 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu02 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
RPC056Hu01 Recombinant Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
EPC056Hu62 Eukaryotic Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
EPC056Hu61 Eukaryotic Matrix Metalloproteinase 14 (MMP14) Positive Control; Immunogen; SDS-PAGE; WB.
APC056Hu01 Active Matrix Metalloproteinase 14 (MMP14) Cell culture; Activity Assays.
PAC056Hu01 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) IHC
PAC056Hu02 Polyclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB,IHC,ICC/IF
MAC056Hu22 Monoclonal Antibody to Matrix Metalloproteinase 14 (MMP14) WB; IHC; ICC; IP.
SEC056Hu ELISA Kit for Matrix Metalloproteinase 14 (MMP14) Enzyme-linked immunosorbent assay for Antigen Detection.
CMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
LMC056Hu Multiplex Assay Kit for Matrix Metalloproteinase 14 (MMP14) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.